A history of regulatory challenges FDA investigators first began documenting problems with Empowers sterile drug production processes in 2015, when the company did not thoroughly investigate how a batch of weight loss injectables became contaminated with bacteria, records say
PubMed Diamond, L.E., Earle, D.C., Rosen, R.C., Willett, M.S., & Molinoff, P.B
86,87 Differing from the effects observed in T2DM, the therapeutic efficacy of dulaglutide for MASLD is not particularly compelling based on current statistics
A randomized, double-blind, positive-controlled, prospective, dose-response clinical study to evaluate the efficacy and tolerability of an aqueous extract of Terminalia bellerica in lowering uric acid and creatinine levels in chronic kidney disease subjects with hyperuricemia